Barclays’s SeaStar Medical ICU Stock Holding History

Barclays’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.49K	Buy	633 +629	+15,725%	+$2.26K	﹤0.01%	4933
2026 Q2	$15	Buy	+4	New	+$15	﹤0.01%	5292
2024 Q3	–	Sell	-583	Closed	-$44.3K	–	5370
2024 Q2	$44.3K	Buy	+583	New	+$62.5K	﹤0.01%	4249

Other funds holding ICU

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Barclays's ICU Position: Q3 2026 in Review

Barclays increased its SeaStar Medical (ICU) stake by 15,725% in Q3 2026, buying an estimated $2.26K and bringing the position to 633 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #4933.

Barclays first reported a position in ICU in Q2 2024 and has held it in 3 quarters since. The position peaked at $44.3K in Q2 2024. 8 funds tracked by Wall St. Rank hold ICU as of Q3 2026.

Barclays held 633 shares of SeaStar Medical worth $2.49K as of Q3 2026.
Barclays bought 629 SeaStar Medical shares in Q3 2026, an estimated $2.26K.
SeaStar Medical made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4933 holding.
Barclays first reported a position in SeaStar Medical in Q2 2024 and has held it in 3 quarters since.
Barclays's SeaStar Medical position peaked at $44.3K in Q2 2024.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.